뉴스 검색결과 23건

• 
  Alteogen Sees Temporary Dip in Investor Sentiment Market Turns Cautious[K-Bio Pulse] 2026.01.30
• 
  2% Royalty Shock at Alteogen Ripples Through Korean Biotech[K-Bio Pulse] 2026.01.29
• 
  NGeneBio Hits Upper Price Limit After Adopting LG AI Research Institute’s Solution[K-Bio Pulse] 2026.01.28
• 
  ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 2025.11.19
• 
  Barriers Blocking K-Bio’s Leap Forward 2025.11.14
• 
  Biotech Stocks Rally, Woojung Bio Shaken on Deal Speculation[K-Bio Pulse] 2025.11.11
• 
  Rokit Healthcare Soars on U.S. Medical Approval; Huons, Sears Rally[K-Bio Pulse] 2025.10.22
• 
  Alteogen “FDA Approves Subcutaneous Version of Keytruda” 2025.09.21
• 
  KoBioLabs Wins U.S. Patent for Natural GLP-1 Obesity Therapy[K-Bio Pulse] 2025.09.04
• 
  ‘Keytruda SC’ FDA Approval…Obesity Drug Battle in Europe[Monthly K-bio Pulse] 2025.09.03